Thrombin at Biology Products
STag Thrombin Purification Kit from Novagen
Description:Request Info...
Company:Novagen
Thrombin from Novagen
Description:Restriction Grade
Thrombin is a highly purified preparation qualified to specifically cleave target proteins produced with appropriate vectors. The preparation is functionally tested for activity with fusion proteins and is free of detectable contaminating proteases. Prepared from human plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV. Throm...
Company:Novagen
Thrombin at Biology Technology
Thrombin at Medicine News
Thrombin at Medicine Products
BD Vacutainer® Specialty Tubes - Thrombin
Description:BD Vacutainer® Specialty Tubes -
Thrombin...
Company:BD Diagnostic Systems
STA THROMBIN 10
Description:Determination of the
Thrombin Time by STA Analyzers. Freeze-dried human
thrombin (1.5NIH units/mL) with calcium....
Company:Diagnostica Stago, Inc.
STA THROMBIN 2
Description:Determination of the
Thrombin Time by STA Analyzers. Freeze-dried human
thrombin (1.5NIH units/mL) with calcium....
Company:Diagnostica Stago, Inc.
Factor V/Prothrombin ASRs*
Description:Nanogen offers reagents for the detection of two genetic mutations associated with thrombosis: the G1691A mutation on the Factor V (Leiden) gene and the G20210A mutation on the Pro
thrombin gene. Laboratories may use the reagents to create homebrew tests. </f...
Company:Nanogen, Inc.
Antithrombin, Antigen
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
More>>
Thrombin at Medicine Technology
Prothrombin Time Comes in Small (CLIA-Waived) Packages
Determining prothombin levels is necessary to plan or evaluate anticoagulant therapy, to diagnose various inherited conditions, such as hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperative state, antiphospholipid syndrome, hyperhomocystinemia, among ot...
Schering-Plough Announces Presentation of Phase II Trial Results
for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual
Meeting of The American College of Cardiology/i2 Summit
KENILWORTH, N.J., March 12, 2007 /PRNewswire-FirstCall/ --Schering-Plough Corporation announced today that results of thePhase II trial of its novel oral
thrombin receptor antagonist (TRA)SCH 530348 will be presented at the 2007 annual Scientific Sessionsof the of Cardiology (ACC.07)/Innovation in Intervention (i2)Summit, March 24-27 in New Orleans. The Phase II trial, referred toas the...
Thrombin at Medicine Dictionary